HHS Limits Insulin, Epinephrine Prices in Drug Discount Plan

The US Department of Health and Human Services will now require certain health centers funded by the federal government to provide insulin and injectable epinephrine to low-income patients under a federal drug discount program.

The department updated Tuesday the awards terms for health centers that are funded by the US Health Resources and Services Administration to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program.

The action follows President Donald Trump’s executive order signed in April that seeks to lower US drug prices through various actions, ...